Target intelligence / Profile preview

RNA, U6 small nuclear 1257, pseudogene (RNU6-1257P)

Target
RNU6-1257P
Molecular classification
Other, Pseudogene, Small nuclear RNA (snRNA) pseudogene
01

Overview

RNA, U6 small nuclear 1257, pseudogene (RNU6-1257P) is a human pseudogene annotated in reference databases such as HGNC (HGNC:48220), Ensembl (ENSG00000207355), and GeneCards[1][5][7][8][9][10]. It is classified as a processed pseudogene related to the U6 class of small nuclear RNAs (snRNAs), which normally function in the spliceosome complex for pre-mRNA splicing. As a pseudogene, RNU6-1257P does not encode a functional RNA or protein, and there is no evidence linking it to recognized biological functions, disease associations, or drug interactions. It is located on human chromosome 20 (GRCh38: 24,974,171-24,974,280, forward strand)[1][7][8][10]. Like other snRNA pseudogenes, it was likely generated by retrotransposition events but is not considered a therapeutic target or to have mechanistic or biomarker roles in disease[4][6]. RNU6-1257P is a pseudogene, meaning it is a nonfunctional sequence derived from a functional gene or RNA but typically lacking biological activity[1][4][5][10]. No evidence exists that it is druggable, involved in pathology, or used as a biomarker. Standard global and specialist databases (HGNC, Ensembl, GeneCards) uniformly classify it as a pseudogene with no function, role, or target relevance[1][5][7][8][9][10].

Other names
RNU6-1257P

Beyond the preview

Go deeper on RNA, U6 small nuclear 1257, pseudogene (RNU6-1257P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1257, pseudogene (RNU6-1257P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call